Massive 12,000-Patient review shows how well new cholesterol shots work
NCT ID NCT07409636
Summary
This study looked back at the health records of nearly 12,000 adults in China with high cholesterol. Researchers wanted to see how well two newer types of injectable cholesterol medicines worked for people in everyday life, outside of a controlled trial. They compared the effectiveness of inclisiran and a class of drugs called PCSK9 inhibitors by checking how much they lowered patients' 'bad' LDL cholesterol over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.